Published in Cancer Weekly, June 22nd, 1998
The Center for Science in the Public Interest (CSPI) also said the product - sold under the brand-name Olean by Procter & Gamble - causes far more cases of severe digestive upset than the company will admit to.
The CSPI urged the U.S. Food and Drug Administration (FDA) to either withdraw approval of olestra, or to require more prominent and strongly worded labels about its possible effects.
The product, approved in January 1996, is used in some of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly